MYSKA, Vojtech, Samuel GENZOR, Anzhelika MEZINA, Radim BURGET, Jan MIZERA, Michal STYBNAR, Martin KOLARIK, Milan SOVA and Malay Kishore DUTTA. Artificial-Intelligence-Driven Algorithms for Predicting Response to Corticosteroid Treatment in Patients with Post-Acute COVID-19. Diagnostics. Basel: MDPI, 2023, vol. 13, No 10, p. 1-17. ISSN 2075-4418. Available from: https://dx.doi.org/10.3390/diagnostics13101755.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Artificial-Intelligence-Driven Algorithms for Predicting Response to Corticosteroid Treatment in Patients with Post-Acute COVID-19
Authors MYSKA, Vojtech (203 Czech Republic, guarantor), Samuel GENZOR (203 Czech Republic), Anzhelika MEZINA (203 Czech Republic), Radim BURGET (203 Czech Republic), Jan MIZERA (203 Czech Republic), Michal STYBNAR (203 Czech Republic), Martin KOLARIK (203 Czech Republic), Milan SOVA (203 Czech Republic, belonging to the institution) and Malay Kishore DUTTA.
Edition Diagnostics, Basel, MDPI, 2023, 2075-4418.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30203 Respiratory systems
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.600 in 2022
RIV identification code RIV/00216224:14110/23:00133302
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3390/diagnostics13101755
UT WoS 000998282700001
Keywords in English personalised medication recommendation algorithms; artificial intelligence; post-COVID syndrome; prediction model; respiratory system; corticosteroids; eHealth
Tags 14110215, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 5/4/2024 09:21.
Abstract
Pulmonary fibrosis is one of the most severe long-term consequences of COVID-19. Corticosteroid treatment increases the chances of recovery; unfortunately, it can also have side effects. Therefore, we aimed to develop prediction models for a personalized selection of patients benefiting from corticotherapy. The experiment utilized various algorithms, including Logistic Regression, k-NN, Decision Tree, XGBoost, Random Forest, SVM, MLP, AdaBoost, and LGBM. In addition easily human-interpretable model is presented. All algorithms were trained on a dataset consisting of a total of 281 patients. Every patient conducted an examination at the start and three months after the post-COVID treatment. The examination comprised a physical examination, blood tests, functional lung tests, and an assessment of health state based on X-ray and HRCT. The Decision tree algorithm achieved balanced accuracy (BA) of 73.52%, ROC-AUC of 74.69%, and 71.70% F1 score. Other algorithms achieving high accuracy included Random Forest (BA 70.00%, ROC-AUC 70.62%, 67.92% F1 score) and AdaBoost (BA 70.37%, ROC-AUC 63.58%, 70.18% F1 score). The experiments prove that information obtained during the initiation of the post-COVID-19 treatment can be used to predict whether the patient will benefit from corticotherapy. The presented predictive models can be used by clinicians to make personalized treatment decisions.
PrintDisplayed: 10/7/2024 21:08